Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Day One Biopharmaceuticals (DAWN) Other Non-Current Assets (2022 - 2025)

Historic Other Non-Current Assets for Day One Biopharmaceuticals (DAWN) over the last 4 years, with Q3 2025 value amounting to $317000.0.

  • Day One Biopharmaceuticals' Other Non-Current Assets rose 17094.02% to $317000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $317000.0, marking a year-over-year increase of 17094.02%. This contributed to the annual value of $121000.0 for FY2024, which is 4345.79% down from last year.
  • Day One Biopharmaceuticals' Other Non-Current Assets amounted to $317000.0 in Q3 2025, which was up 17094.02% from $183000.0 recorded in Q2 2025.
  • In the past 5 years, Day One Biopharmaceuticals' Other Non-Current Assets registered a high of $487000.0 during Q1 2023, and its lowest value of $117000.0 during Q2 2024.
  • Over the past 4 years, Day One Biopharmaceuticals' median Other Non-Current Assets value was $215000.0 (recorded in 2025), while the average stood at $266466.7.
  • As far as peak fluctuations go, Day One Biopharmaceuticals' Other Non-Current Assets surged by 19515.15% in 2023, and later plummeted by 6570.84% in 2024.
  • Over the past 4 years, Day One Biopharmaceuticals' Other Non-Current Assets (Quarter) stood at $469000.0 in 2022, then crashed by 54.37% to $214000.0 in 2023, then crashed by 43.46% to $121000.0 in 2024, then soared by 161.98% to $317000.0 in 2025.
  • Its Other Non-Current Assets was $317000.0 in Q3 2025, compared to $183000.0 in Q2 2025 and $215000.0 in Q1 2025.